Mouse monoclonal [DR5-01-1] antibody to DR5 (APC).
Specificity
The antibody recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1-5 µg/ml; Positive Control: JURKAT human peripheral blood leukemia T cell line.
Reactivity
Human
Immunogen
Recombinant fusion protein of human IgG heavy chain and extracellular domain of DR5.
Host
Mouse
Clonality
Monoclonal
Clone ID
DR5-01-1
Isotype
IgG1
Conjugate
APC
Excitation: 645nm, Emission: 660nm
Purification
This antibody is conjugated with Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Concentration
100 µg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Separation of TRAIL-R2 transfected HEK-293 stained with Anti-DR5 Antibody [DR5-01-1] (APC) (A121839), (concentration in sample 1,7 µg/ml, red-filled) from TRAIL-R2 transfected HEK-293 stained using Mouse IgG1 kappa Isotype Control [MOPC-21] (APC) (A86198), (concentration in sample 1,7 µg/ml, same as CD262 APC concentration, black-dashed) in flow cytometry analysis (surface staining) of TRAIL-R2 transfected HEK-293 suspension.
Publishing research using Anti-DR5 Antibody [DR5-01-1] (APC) (A121839)? Please let us know so that we can list the citation on this page.
Proteins predicted to interact with DR5
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.